Edition:
India

People: Dynasil Corporation of America (DYSL.OQ)

DYSL.OQ on NASDAQ Stock Exchange Capital Market

1.09USD
23 May 2019
Change (% chg)

-- (--)
Prev Close
$1.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,487
52-wk High
$1.58
52-wk Low
$0.75

Bowdring, Robert 

Mr. Robert J. Bowdring is Chief Financial Officer, Corporate Controller of the Company,, effective February 1, 2016. Mr. Bowdring, 58, has served as Corporate Controller for the Company since March of 2013. Additionally, he brings over 35 years of accounting and financial experience to his new position. Prior to joining Dynasil, Mr. Bowdring served as the Chief Financial Officer for INVO Bioscience, a publicly traded development-stage infertility medical device company based in Medford, Massachusetts, from 2008 until 2013. He continues as a member of the Board of Directors of INVO Bioscience. He also served as Chief Financial Officer of Cyphermint, Inc. from 2003 to 2008, and as Vice President and Corporate Controller for Lifeline Systems from 1989 to 2003. Prior to 1989, Mr. Bowdring held positions of increasing responsibility at Remanco, Inc., Warburton's Inc., Cyborg Corporation, and Technogenics, Inc. Mr. Bowdring has a B.A. in Accounting from the University of Massachusetts.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --